Lysozyme is a small protein, roughly 14 kilodaltons in size, that kills bacteria by breaking apart their cell walls. Found in tears, saliva, nasal mucus, breast milk, and many other bodily secretions, it acts as a frontline defender in your immune system before any white blood cell ever arrives on the scene. But lysozyme is more than a simple germ-killer: it has a surprisingly rich story involving convergent evolution across distant species, a quiet role in certain rare diseases, and practical uses ranging from cheese-making to experimental antibiotic alternatives.
A Protein That Cracks Open Bacteria
Lysozyme targets a structural material called peptidoglycan, which forms the rigid outer shell of most bacteria. You can think of peptidoglycan as a mesh made of sugar chains cross-linked by short protein bridges. It is what gives a bacterium its shape and keeps it from bursting under its own internal pressure. Lysozyme works by cutting specific bonds in those sugar chains, specifically the link between two sugar molecules abbreviated NAM and NAG that alternate along the chain. Once enough of those bonds are severed, the mesh loses its integrity, water rushes into the bacterium, and the cell bursts.
Two amino acids in the lysozyme molecule do most of the heavy lifting during this reaction: glutamic acid at position 35 and aspartic acid at position 52. When researchers chemically swapped these two residues for close but inactive cousins, the enzyme’s activity dropped to less than 4 percent of normal, even though the modified lysozyme could still latch onto its target sugar chain just as well as the original. That experiment provided direct proof that these two specific spots are the catalytic heart of the enzyme.
Where Your Body Deploys It
Lysozyme is present across a wide range of tissues and secretions. Tears contain high concentrations of it, which is one reason your eyes can fend off infection despite being constantly exposed to airborne bacteria. Saliva, nasal secretions, and the mucus lining your airways and gut all carry it too. Breast milk is another rich source, helping protect newborns whose own immune systems are still developing. Certain white blood cells, particularly neutrophils and macrophages, also produce and release lysozyme as part of their pathogen-killing toolkit.
Because lysozyme is a natural component of these secretions rather than something your body activates only when it detects a threat, it belongs to what immunologists call the innate immune system. It is always present, always working, and does not need prior exposure to a specific pathogen to be effective. This makes it fundamentally different from antibodies, which your adaptive immune system tailors to particular invaders after encountering them.
Why It Works Better Against Some Bacteria Than Others
Not all bacteria are equally vulnerable to lysozyme, and the main reason comes down to cell wall architecture. Bacteria broadly fall into two camps based on a staining test developed in the 1800s. One group has a thick, exposed peptidoglycan layer that lysozyme can reach easily. The other group wraps a thinner peptidoglycan layer inside an additional outer membrane that acts like a shield. That outer membrane blocks lysozyme from reaching its target.
Research comparing hen egg white lysozyme (the most studied version) against different bacterial cell walls found it was far more effective against the exposed-peptidoglycan type, such as the test organism Micrococcus lysodeikticus, than against bacteria with the protective outer membrane. However, the body has a workaround. A protein called lactoferrin, also found in tears and mucus, can destabilize that outer membrane. Once lactoferrin punches holes in the shield, lysozyme gains access to the peptidoglycan underneath and can do its job. The two proteins work as a team in your secretions, a partnership that is more effective than either protein alone.
Killing Without Cutting
Lysozyme has a second, less intuitive way of attacking microbes that does not involve its enzymatic activity at all. Researchers discovered this when they heat-treated a version of lysozyme until its enzyme function was completely destroyed. The denatured protein still killed bacteria. Further investigation showed that short peptide sequences from the lysozyme molecule, particularly segments that form structures with one water-attracting side and one water-repelling side, can punch directly into microbial membranes and disrupt them. This membrane-disturbing action was demonstrated against bacteria, fungi, and plant cells, but did not damage red blood cells, suggesting a degree of selectivity.
This dual mode of action, one enzymatic and one physical, helps explain why lysozyme remains effective against a broader range of organisms than you might expect from a single enzyme. It also means that even fragments of lysozyme or partially degraded forms can still contribute to immune defense.
How Bacteria Fight Back
Bacteria are not passive targets. Many disease-causing species have evolved chemical modifications to their peptidoglycan that make it resistant to lysozyme cleavage. The most common strategies involve tacking small chemical groups onto the sugar chains near the exact bond that lysozyme cuts. These additions physically block the enzyme from fitting into its cleavage site, like jamming a lock so the key can’t turn.
Helicobacter pylori, the bacterium behind most stomach ulcers, uses two enzymes called PgdA and PatA to modify its peptidoglycan. Mutant strains missing both modifications were five times more sensitive to lysozyme than the wild-type parent strain, and adding lactoferrin at concentrations found naturally in the stomach made the difference even more dramatic. The two modifications worked together synergistically: losing just one had a modest effect, but losing both left the bacterium highly vulnerable. This is a concrete example of how a pathogen’s cell wall chemistry directly determines whether it can survive your body’s lysozyme defenses.
Bacillus subtilis, a soil bacterium, takes a somewhat different approach. It activates a stress-response gene that switches on two separate cell wall modification pathways at once: one adds acetyl groups to peptidoglycan, and the other adds alanine to molecules called teichoic acids in the cell wall. Either modification alone provides little protection, but together they confer the same level of resistance as the master gene that controls them both. This redundancy makes the defense robust: a single random mutation is unlikely to disable both pathways simultaneously.
A Window Into Evolutionary Creativity
One of the more striking stories in lysozyme biology involves animals that ferment plant material in a specialized foregut, the way cows use their rumen. In these animals, symbiotic bacteria break down cellulose, and the animal then digests those bacteria further along in its gut to extract nutrients. To efficiently digest bacterial cells in the harsh acidic environment of the stomach, these animals evolved lysozymes specially adapted to work at low pH.
What makes this remarkable is that the same adaptation arose independently in unrelated lineages. Cows and their relatives evolved stomach-adapted lysozymes. Then colobine monkeys, like langurs, independently evolved their own foregut fermentation system and recruited lysozyme for the same digestive role. When researchers sequenced langur stomach lysozyme, they found it had gained amino acid similarities to cow stomach lysozyme, even though the two species diverged tens of millions of years ago. The langur enzyme had evolved roughly twice as fast as lysozymes in other primates, and the researchers estimated that positive selection drove about half of that accelerated change.
The story does not stop with mammals. The hoatzin, a bizarre leaf-eating bird from South America, also ferments plant material in a crop-like foregut. Its stomach lysozyme shows biochemical convergence and parallel amino acid substitutions with the mammalian examples, despite more than 300 million years of independent evolution separating birds from mammals. Three separate lineages arriving at the same molecular solution to the same ecological problem is a textbook case of convergent evolution, and lysozyme is one of the clearest demonstrations of it anywhere in biology.
When Lysozyme Goes Wrong
In rare cases, mutations in the human lysozyme gene cause the protein to misfold and aggregate into insoluble fibers called amyloid. This condition, hereditary lysozyme amyloidosis, was first identified in two British families in the early 1990s. In one family, an isoleucine-to-threonine swap at position 56 caused the disease; in the other, an aspartic acid-to-histidine change at position 67 was responsible. Both mutations destabilize the protein’s normal folded shape enough that it begins clumping into the stiff fibers that characterize all amyloid diseases.
Lysozyme amyloidosis typically affects the kidneys, gastrointestinal tract, and salivary or tear glands, producing symptoms like declining kidney function, chronic diarrhea, and dry eyes or mouth. A more recently identified variant, involving a leucine-to-serine substitution at codon 102, was associated with an unusual presentation that included features not previously reported for lysozyme amyloidosis. The disease remains rare, with only a handful of causative mutations identified worldwide, but it illustrates how a small change in a single protein can have serious systemic consequences.
Lysozyme as a Clinical Marker
Because certain white blood cells produce lysozyme in quantity, elevated lysozyme levels in the blood can signal conditions where those cells are unusually active or numerous. Researchers investigated serum lysozyme as a diagnostic marker for inflammatory bowel diseases in the 1970s. They found that average levels were significantly higher in Crohn’s disease than in ulcerative colitis or healthy controls, and that levels correlated with disease severity and extent. However, there was substantial overlap between groups, limiting the test’s usefulness for diagnosing any individual patient.
Lysozyme has also been evaluated in sarcoidosis, a condition where immune cells form inflammatory clusters in various organs. A review of serum biomarkers found that while lysozyme was not the most sensitive marker for confirming sarcoidosis, it showed relatively high specificity, meaning elevated levels were fairly reliable for ruling the disease out when absent. In practice, clinicians tend to use lysozyme alongside other markers rather than relying on it alone.
Cheese, Wine, and Food Preservation
Outside the body, lysozyme has a well-established commercial role in the food industry. The main commercial source is hen egg white, which contains it in abundance. In cheese-making, lysozyme is added to prevent a defect called late blowing, where the bacterium Clostridium tyrobutyricum ferments lactate inside the cheese and produces gas, creating unwanted holes and off-flavors in hard and semi-hard varieties. Lysozyme targets this organism specifically without disrupting the lactic acid bacteria responsible for proper cheese ripening.
Interest in lysozyme as a food preservative has grown partly because consumers are increasingly wary of synthetic preservatives. Because lysozyme is a natural component of the human immune system and has low toxicity, it fits the growing market demand for “clean label” ingredients. Research continues into modifying lysozyme molecules to broaden their effectiveness, since the native enzyme works best against bacteria with exposed peptidoglycan and has limited activity against many food spoilage organisms that carry an outer membrane shield.
Engineered Lysozymes and Future Antimicrobials
With antibiotic resistance becoming a more urgent public health problem, lysozyme and its relatives have attracted attention as potential therapeutic agents. One avenue of research focuses on endolysins, which are lysozyme-like enzymes produced by bacteriophages (viruses that infect bacteria). When a phage finishes replicating inside a bacterium, it deploys endolysins to destroy the host cell wall from within, releasing new phage particles. Applied externally, these endolysins can destroy bacteria with exposed peptidoglycan rapidly and effectively, and because they target fundamental cell wall structures, bacteria may have a harder time evolving resistance to them than to conventional antibiotics.
On the biotechnology side, researchers have successfully produced recombinant human lysozyme in transgenic rice cells. One project achieved expression levels approaching 4 percent of total soluble protein, and purified the recombinant protein to over 95 percent homogeneity. The goal of such work is to develop scalable, plant-based production systems for human lysozyme that could supply it for pharmaceutical, food, or agricultural uses without relying on animal sources.
A Favorite Molecule of Structural Biologists
Lysozyme holds a unique place in the history of molecular biology. Hen egg white lysozyme was the first enzyme whose three-dimensional structure was solved by X-ray crystallography, work led by David Phillips in the 1960s. That achievement was a landmark because it let scientists see, for the first time, exactly how an enzyme’s shape relates to its function. The active-site cleft where the sugar chain fits, the positions of those two critical amino acids, the way the protein folds around its substrate: all of this became visible in atomic detail.
Since then, lysozyme has remained a model system for crystallographers. It crystallizes easily, diffracts X-rays well, and is stable enough to withstand a wide range of experimental conditions. Generations of structural biology students have cut their teeth on lysozyme crystals, and the protein continues to serve as a benchmark for new techniques in the field.
Lysozyme Beyond Humans and Chickens
Lysozyme is not unique to vertebrates. It is widespread across the animal kingdom and even found in some plants. Research on the earthworm Dendrobaena veneta detected lysozyme-like activity in the coelomic fluid (the invertebrate equivalent of blood), in immune cells, in the intestine, and even in cocoons. When the earthworms were exposed to Escherichia coli, lysozyme activity in their coelomic fluid tripled within four hours, and activity in their immune cells quadrupled. The researchers also found multiple forms of lysozyme with different electric charges, suggesting the earthworm uses several variants for different purposes.
This ubiquity underscores how ancient and fundamental lysozyme-based defense is. Invertebrates lack the adaptive immune system that vertebrates rely on, so innate defenses like lysozyme carry even more of the antimicrobial burden. The fact that a protein performing essentially the same function appears in organisms as different as humans, chickens, earthworms, and plants speaks to its effectiveness as a first-line weapon against bacteria, a role it has filled for hundreds of millions of years.